Skip to main content
SpringerLink
Log in

Anti-neoplastics

Thrombocytopenia and pancytopenia: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Thang SP, et al. Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging 45: 262-277, No. 2, Feb 2018. Available from: URL: http://doi.org/10.1007/s00259-017-3821-2 - Australia

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-neoplastics. Reactions Weekly 1686, 41 (2018). https://doi.org/10.1007/s40278-018-41105-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41105-y

Search

Navigation